A new trading day began on Friday, with Protara Therapeutics Inc (NASDAQ: TARA) stock price up 4.05% from the previous day of trading, before settling in for the closing price of $5.18. TARA’s price has ranged from $1.60 to $10.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 16.18%. With a float of $30.63 million, this company’s outstanding shares have now reached $34.32 million.
Let’s look at the performance matrix of the company that is accounted for 27 employees. In terms of profitability, gross margin is 77.4%, operating margin of -3798.26%, and the pretax margin is -3480.79%.
Protara Therapeutics Inc (TARA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Protara Therapeutics Inc is 10.74%, while institutional ownership is 28.15%. The most recent insider transaction that took place on Sep 12 ’24, was worth 215,836. In this transaction 10% Owner of this company sold 126,301 shares at a rate of $1.71, taking the stock ownership to the 45,000 shares. Before that another transaction happened on Sep 11 ’24, when Company’s 10% Owner sold 32,600 for $1.71, making the entire transaction worth $55,880. This insider now owns 51,500 shares in total.
Protara Therapeutics Inc (TARA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.18% per share during the next fiscal year.
Protara Therapeutics Inc (NASDAQ: TARA) Trading Performance Indicators
Here are Protara Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.82, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.98 in one year’s time.
Technical Analysis of Protara Therapeutics Inc (TARA)
Protara Therapeutics Inc (NASDAQ: TARA) saw its 5-day average volume 1.07 million, a positive change from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 17.80%. Additionally, its Average True Range was 0.67.
During the past 100 days, Protara Therapeutics Inc’s (TARA) raw stochastic average was set at 42.71%, which indicates a significant increase from 36.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 245.35% in the past 14 days, which was higher than the 117.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.22, while its 200-day Moving Average is $2.74. Nevertheless, the first resistance level for the watch stands at $5.53 in the near term. At $5.67, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.93. If the price goes on to break the first support level at $5.13, it is likely to go to the next support level at $4.87. The third support level lies at $4.73 if the price breaches the second support level.
Protara Therapeutics Inc (NASDAQ: TARA) Key Stats
With a market capitalization of 192.48 million, the company has a total of 20,630K Shares Outstanding. Currently, annual sales are 0 K while annual income is -40,420 K. The company’s previous quarter sales were 0 K while its latest quarter income was -11,220 K.
